Dr. Alexander Bondoc · The role of surgical shunts in the treatment of pediatric portal hypertension
Follow
Article1 min read·Published Jul 2019Older

The role of surgical shunts in the treatment of pediatric portal hypertension

pubmed.ncbi.nlm.nih.gov shows its articles on its own site.

Read the article on pubmed.ncbi.nlm.nih.gov ↗

Article · Jul 2019 · 1 min read

In brief

In brief

Retrospective analysis of 34 pediatric portal hypertension patients treated with surgical shunts demonstrates favorable outcomes with 71% one-year patency and low complication rates. Meso-Rex bypass was the most common procedure, with 29% experiencing shunt complications requiring intervention. Study supports surgical shunts as effective treatment for medically refractory pediatric portal hypertension.

Written by the GCMD Library team from the article.

Alexander Bondoc

Background: Portal diversion by surgical shunt plays a major role in the treatment of medically refractory portal hypertension. We evaluate our center's experience with surgical shunts for the treatment of pediatric portal hypertension. Methods: All patients who underwent surgical shunt at a single institution from 2008 to 2017 were reviewed. The primary outcome was intervention-free shunt patency. Results: In this study, 34 pediatric patients underwent portal shunt creation. The median age was 7.7 years (interquartile range 4.3-12.0). Twenty-nine patients (85%) had prehepatic portal hypertension and 5 patients (15%) had intrahepatic portal hypertension. The primary manifestations of portal hypertension were esophageal varices (97%) and gastrointestinal bleeding (77%). Eighteen patients (53%) underwent meso-Rex bypass, 10 patients (29%) underwent splenorenal shunt, and 6 patients (18%) underwent mesocaval shunt. Outcomes were notable for minimal wound complications (9%), rebleeding events (12%), and mortality (3%). In the postoperative setting, 10 patients (29%) experienced a shunt complication (occlusion or stenosis), 4 of which occurred in the early postoperative period and required urgent intervention. The 1-year and 5-year "primary patency" patency rates were 71% and 66%, respectively. Conclusion: Children suffer significant morbidity from the sequelae of portal hypertension. Our experience reinforces the feasibility of surgical shunts as an effective treatment option ass

Statements in this article

  1. Portal diversion by surgical shunt plays a major role in the treatment of medically refractory portal hypertension.

    EstablishedBackground
  2. In this cohort, 85% of patients had prehepatic portal hypertension and 15% had intrahepatic portal hypertension.

    ResearchResults
  3. The primary manifestations of portal hypertension were esophageal varices in 97% of patients and gastrointestinal bleeding in 77%.

    ResearchResults
  4. Meso-Rex bypass was performed in 53% of patients, splenorenal shunt in 29%, and mesocaval shunt in 18%.

    ResearchResults
  5. Wound complications occurred in 9% of patients, rebleeding events in 12%, and mortality in 3%.

    ResearchResults
  6. Shunt complications including occlusion or stenosis occurred in 29% of patients postoperatively.

    ResearchResults
  7. Four shunt complications occurred in the early postoperative period and required urgent intervention.

    ResearchResults
  8. The 1-year primary patency rate was 71% and the 5-year primary patency rate was 66%.

    ResearchResults
  9. Surgical shunts are a feasible and effective treatment option for pediatric portal hypertension.

    RecommendationConclusion

Read it at the source ↗

Intelligent Search· scoped to this article · not medical adviceSearch the whole library →
Only a few other public items share this field — go deeper there →
GCMD Library — educational content from recorded physician discussions, not medical advice.